CION Ameerpet
Prognosis & Recurrence · Reviewed by CION Oncologists · NABH Accredited
Vaginal Vault Recurrence — The One That Is Often Cured
If you have found this page after being told the cancer has returned at the top of your vagina, start here: this is the most treatable pattern of recurrence there is, and in a woman who did not have pelvic radiotherapy the first time, it is frequently cured. Salvage treatment combining external beam radiotherapy with brachytherapy achieves lasting control in a substantial proportion of cases. That is a genuinely different prospect from what the word “recurrence” usually implies. This page explains why the vault behaves this way, why your original treatment matters so much, and why bleeding should never be sat on.
- The most favourable recurrence — and frequently curable
- Bleeding is the usual first sign — report it, do not wait
- Prior pelvic radiotherapy is the key variable — it determines the options
- Brachytherapy matters twice — preventing it, and treating it
17+
Cancer Specialists
on Panel
on Panel
35+
Centres
Across India
Across India
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
Why Recurrence Happens There
Understanding the anatomy makes the rest of the page make sense.
- The vault is where the uterus was. After hysterectomy the top of the vagina is closed, and that surgical join is the commonest site for isolated recurrence — cells left behind microscopically at the time of surgery can grow there.
- It is visible. Unlike almost every other site of recurrence, this one can be seen directly on a speculum examination. That is exactly why follow-up appointments include one rather than a scan.
- It bleeds. Which gives it the same advantage the original cancer had — a symptom that brings women in early. Bleeding after treatment is the commonest way vault recurrence declares itself.
- It is often the only site. Where imaging confirms recurrence is genuinely confined to the vault, treatment can be directed at it with the intention of curing rather than controlling.
- And it is accessible to radiotherapy. Brachytherapy delivers a high dose directly to vaginal tissue while sparing the surrounding organs, which is what makes effective treatment possible. See vault brachytherapy.
Did You Know? The single most consequential fact about vault recurrence is one most women have never been asked to think about: whether you had pelvic radiotherapy as part of your original treatment. If you did not, the vault can be treated with full-dose radiotherapy now, and that is what makes cure achievable. If you did, the surrounding tissues — bladder, bowel, the vaginal tissue itself — have already absorbed close to their safe lifetime dose, and what can be given is limited. This is why women who had brachytherapy alone, or no radiotherapy at all, retain an option that others do not. It is worth knowing which category you are in. Sources: NCCN Clinical Practice Guidelines in Oncology — Uterine Neoplasms; ESGO–ESTRO–ESP guidelines for the management of patients with endometrial carcinoma; PORTEC trial data on vaginal recurrence and salvage radiotherapy.
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
What Your Original Treatment Determines
Four situations, and which one you are in shapes everything that follows.
| What you had originally | What is available now |
|---|---|
| No radiotherapy at all | The best position for salvage. Full-dose external beam radiotherapy to the pelvis combined with brachytherapy to the vault, given with curative intent, achieving durable control in a substantial proportion of women. |
| Vault brachytherapy only | Also favourable. Brachytherapy treats a small volume of vaginal tissue, so most of the pelvis has not been irradiated and external beam radiotherapy generally remains available. Worth establishing precisely which you had. |
| Full pelvic radiotherapy | More constrained. The surrounding tissues have already received close to their cumulative tolerance. Options include limited re-irradiation in selected cases, surgery, or systemic treatment — a situation for a specialist centre. See treating recurrence. |
| Pelvic radiotherapy and chemotherapy | The most constrained, and still not without options. Surgery for carefully selected central recurrence, and systemic treatment guided by molecular profile. Molecular testing matters particularly here. See molecular classification. |
Find out exactly what you had, and carry it with you. “I had radiotherapy” is not enough — brachytherapy alone and full pelvic radiotherapy lead to entirely different conversations. Your treatment summary should state it, and it is worth having a copy in your own hands.
Bleeding and Waiting for an Appointment?
Examination the same week rather than next month — and if it is recurrence, being seen early matters.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Bleeding After Treatment Needs Looking At
It usually is not recurrence. When it is, this is the one most often cured — and early matters.
What Happens If Vault Recurrence Is Found
A defined sequence that moves quickly.
Examination and biopsy
The vault is examined and any abnormal area biopsied. Confirmation by tissue matters here, because changes after radiotherapy and surgery can look abnormal without being tumour. It is quick and it is the step everything else rests on.
Imaging to confirm it is isolated
The question that determines whether treatment is given to cure or to control. PET-CT is well suited to establishing whether the vault really is the only site, and this is one of its strongest indications. See PET-CT.
A tumour board decision
Radiotherapy, surgery and systemic treatment all have a claim depending on what you had before and what imaging shows. The sequence is a genuine judgement and should not be made by one specialty alone.
Salvage radiotherapy, where possible
External beam radiotherapy to the pelvis combined with brachytherapy to the vault, over several weeks as an outpatient. It is demanding — bladder, bowel and vaginal side effects are real — and it is given with the intention of curing you. See pelvic radiation.
Vaginal care afterwards, deliberately
Radiotherapy to the vagina causes narrowing and dryness, and dilator use plus moisturisers work considerably better started early than started late. This is frequently under-discussed and it affects the years afterwards. See vaginal health.
Want a Second Opinion on Salvage Treatment?
Bring your original treatment summary. Whether curative treatment is possible, assessed properly. The opinion is free.
The Other Half: Preventing It
The sheet title points at this and it is worth stating — brachytherapy features twice in this story.
- Adjuvant vault brachytherapy reduces vault recurrence. Given after surgery to women at intermediate risk, it lowers the chance of the cancer returning at the vault. That is what it is for, and it is why it is offered to women who feel entirely well.
- It is far better tolerated than pelvic radiotherapy. A small volume of vaginal tissue is treated rather than the whole pelvis, so bowel and bladder side effects are substantially fewer. For many women it is a few short outpatient sessions.
- It preserves options for later. An under-appreciated advantage. Because brachytherapy alone irradiates only a small volume, external beam radiotherapy generally remains available if recurrence ever occurs. Full pelvic radiotherapy does not leave that door as open.
- Not everyone needs it. Women with low-risk disease frequently need no radiotherapy at all, and being told so is good practice rather than under-treatment. See treatment after surgery.
- Ask which you are being offered and why. Brachytherapy alone, pelvic radiotherapy, or neither — and what drove the recommendation. It is a fair question with a specific answer.
Why Salvage Treatment Belongs in a Radiotherapy Centre
Curative treatment here means external beam and brachytherapy together, planned by people who do both.
Vault brachytherapy on site
Image-guided pelvic radiation
Tumour board for every diagnosis
Follow-up you can actually keep
Survivorship care that is actually offered
Second opinions welcomed, not resented
Take The Next Step
Know Exactly What You Had
Brachytherapy alone and full pelvic radiotherapy lead to entirely different conversations later.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
Vault Recurrence — Frequently Asked Questions
Can vaginal vault recurrence be cured?
Frequently, yes — this is the most favourable pattern of recurrence in endometrial cancer. In a woman who did not receive pelvic radiotherapy as part of her original treatment, salvage therapy combining external beam radiotherapy to the pelvis with brachytherapy to the vault achieves durable local control in a substantial proportion of cases, and it is given with the intention of curing rather than controlling. The essential conditions are that the recurrence is genuinely isolated to the vault, confirmed by imaging, and that radiotherapy remains available. That makes this a very different situation from what the word "recurrence" generally implies.
What is the first sign of vault recurrence?
Vaginal bleeding, in most cases. That is the reason bleeding after treatment for endometrial cancer should be reported when it happens rather than saved for the next scheduled appointment. It has benign explanations too — fragile tissue after radiotherapy is common — and the examination that distinguishes them takes minutes. Vault recurrence is one of the few recurrences that can be seen directly on a speculum examination, which is precisely why follow-up appointments include one. Some recurrences are found this way in women who had noticed nothing at all.
Why does it matter whether I had radiotherapy before?
Because it determines whether radiotherapy remains available now, and at the vault that is the difference between the most effective curative option and having to look elsewhere. Normal tissues can only safely absorb a certain total radiation dose across a lifetime. Full pelvic radiotherapy uses much of that allowance. Vault brachytherapy alone treats only a small volume of vaginal tissue, so most of the pelvis is untouched and external beam radiotherapy generally remains open. This is why "I had radiotherapy" is not enough detail — find out exactly which you had.
Why was I offered brachytherapy after surgery when I felt fine?
Because it reduces the chance of exactly this — recurrence at the vault — in women at intermediate risk. It is preventive treatment given to someone who is well, which is why the reasoning deserves to be explained rather than assumed. It is also considerably better tolerated than pelvic radiotherapy, treating a small volume of vaginal tissue rather than the whole pelvis, with far fewer bowel and bladder effects. It has a further advantage that is rarely mentioned: because it irradiates so little, it leaves external beam radiotherapy available should it ever be needed later.
What if I have already had pelvic radiotherapy?
The options are more constrained and they are not absent. Limited re-irradiation is possible in carefully selected cases where the previous dose distribution allows it. Surgery may be considered for recurrence confined to the vault or central pelvis, and for a small selected group with central recurrence after radiotherapy, more extensive surgery can offer cure. Systemic treatment guided by your tumour's molecular profile is the other route, and mismatch repair testing matters particularly here. This is a situation that warrants assessment at a centre that handles salvage treatment regularly.
Medical disclaimer: This page provides general information about vaginal vault recurrence of endometrial cancer, reviewed by a CION oncologist. It is not a substitute for individual medical advice. Any vaginal bleeding after treatment for endometrial cancer should be reported to your treating team when it occurs rather than deferred to a scheduled appointment. Treatment options depend on the extent of recurrence and on radiotherapy previously received, and should be decided following multidisciplinary discussion.